Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(17):1179; doi:10.1093/jnci/djj385
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2006.

NEWS

In Brief

Gleevec Can Cause Heart Failure

Gleevec, a cancer drug wildly successful at combating leukemia, may be bad for the heart.

Thomas Force, M.D., of Thomas Jefferson University and colleagues showed that Gleevec caused severe heart failure in ten leukemia patients who took the drug. They suggest that patients should not be prevented from taking the drug but should be monitored for heart problems or damage.

The study was published online July 23 in Nature Medicine.

Patients Report Father's Family History of Breast Cancer Less Often Than Mother's

Patients report breast cancer more frequently on their mother's side than their fathers, a study reports.

In an analysis of survey data from April 2003 to March 2005 from the Women's Health Clinic, John M. Quillin, Ph.D., of Virginia Commonwealth University and colleagues found that 16% of participants reported breast cancer in their mother's family, while only 10% reported breast cancer in their fathers.

Quillin says, "Disease prevention scientists need to be mindful of this discrepancy when using reported family history to design and implement breast cancer health interventions."

The study was published in the September issue of the American Journal of Preventive Medicine.

Skin Cancer In Dark-Skinned Patients Is Less Common but More Fatal

Skin cancer may be more dangerous for people with darker skin.

Hugh Gloster, M.D., of the University of Cincinnati in Ohio, and Kenneth Neal, M.D., retrospectively examined clinical data on skin cancer collected over the last 50 years by medical centers in North America, Africa, and Asia. They observed that dark-skinned races develop nonmelanoma skin cancer less commonly than whites, but when they do develop the disease, it is more aggressive and death rates are higher.

The research was presented July 27 at the meeting of the American Academy of Dermatology.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?